Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure
达格列净可减轻无已知心力衰竭的2型糖尿病患者的全身炎症反应。
期刊:Cardiovascular Diabetology
影响因子:10.6
doi:10.1186/s12933-024-02294-z
Wang, Dennis D; Naumova, Anna V; Isquith, Daniel; Sapp, Jamie; Huynh, Kim A; Tucker, Isabella; Balu, Niranjan; Voronyuk, Anna; Chu, Baocheng; Ordovas, Karen; Maynard, Charles; Tian, Rong; Zhao, Xue-Qiao; Kim, Francis